ANI PHARMACEUTICALS, INC Other Noncash Income (Expense)
ANI PHARMACEUTICALS, INC (ANIP) reported Other Noncash Income (Expense) of -$3.39 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2015-08-04
- ANI PHARMACEUTICALS, INC other noncash income (expense) for the quarter ending 2015-06-30 was -$1.71M.
- ANI PHARMACEUTICALS, INC other noncash income (expense) for the quarter ending 2015-03-31 was -$1.68M.
- ANI PHARMACEUTICALS, INC other noncash income (expense) for the quarter ending 2014-12-31 was -$559.00K.
- ANI PHARMACEUTICALS, INC other noncash income (expense) for the quarter ending 2014-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC other noncash income (expense) for fiscal 2014 was -$559.00K.
- ANI PHARMACEUTICALS, INC other noncash income (expense) for fiscal 2013 was -$217.00K.
- ANI PHARMACEUTICALS, INC other noncash income (expense) for fiscal 2012 was -$1.07M.
- ANI PHARMACEUTICALS, INC other noncash income (expense) for fiscal 2010 was $65.81K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|---|
| 2015-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$3.39M 10-Q · filed 2015-08-04 | -$3.95M derived: sum of 3 quarters · filed 2015-08-04 | -$3.95M derived: sum of 4 quarters · filed 2015-08-04 | ||
| 2015-03-31 | -$1.68M 10-Q · filed 2015-05-05 | -$2.24M derived: sum of 2 quarters · filed 2015-05-05 | -$2.24M derived: sum of 3 quarters · filed 2015-05-05 | -$2.24M derived: sum of 4 quarters · filed 2015-08-04 | ||
| 2014-12-31 | -$559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | -$559.00K derived: sum of 2 quarters · filed 2015-02-23 | -$559.00K derived: sum of 3 quarters · filed 2015-08-04 | -$559.00K 10-K · filed 2015-02-23 | ||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2015-08-04 | $0.00 10-Q · filed 2014-11-10 | $0.00 derived: sum of 4 quarters · filed 2015-08-04 | ||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $0.00 10-Q · filed 2015-08-04 | $0.00 derived: sum of 3 quarters · filed 2015-08-04 | $0.00 derived: sum of 4 quarters · filed 2015-08-04 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-05 | $0.00 derived: sum of 2 quarters · filed 2015-05-05 | $0.00 derived: sum of 3 quarters · filed 2015-05-05 | -$195.00K derived: sum of 4 quarters · filed 2015-05-05 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $0.00 derived: sum of 2 quarters · filed 2015-02-23 | -$195.00K derived: sum of 3 quarters · filed 2015-02-23 | -$217.00K 10-K · filed 2015-02-23 | ||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$195.00K derived: sum of 2 quarters · filed 2014-11-10 | -$217.00K 10-Q · filed 2014-11-10 | -$217.29K 10-Q · filed 2013-11-07 | -$260.29K derived: sum of 4 quarters · filed 2014-11-10 | |
| 2013-06-30 | -$195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$217.00K 10-Q · filed 2014-08-07 | -$217.29K 10-Q · filed 2013-08-09 | -$260.29K derived: sum of 3 quarters · filed 2014-08-07 | -$234.55K derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | -$22.00K 10-Q · filed 2014-05-12 | -$65.29K derived: sum of 2 quarters · filed 2014-05-12 | -$39.55K derived: sum of 3 quarters · filed 2014-05-12 | |||
| 2012-12-31 | -$43.29K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$17.55K derived: sum of 2 quarters · filed 2014-02-28 | -$1.07M 10-K · filed 2014-02-28 | |||
| 2012-09-30 | $25.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$1.03M 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | -$1.05M 10-Q · filed 2013-08-09 | |||||
| 2010-12-31 | $65.81K 10-K · filed 2013-02-28 | |||||
| 2009-12-31 | -$60.74K 8-K · filed 2013-01-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |